A framework for advancing sustainable magnetic resonance imaging access in Africa

Autor: Anazodo, U.C., Ng, J.J., Ehiogu, B., Obungoloch, J., Fatade, A., Mutsaerts, H.J.M.M., Secca, M.F., Diop, M., Opadele, A., Alexander, D.C., Dada, M.O., Ogbole, G., Nunes, R., Figueiredo, P., Figini, M., Aribisala, B., Awojoyogbe, B.O., Aduluwa, H., Sprenger, C., Wagner, R., Olakunle, A., Romeo, D., Sun, Y.S., Fezeu, F., Orunmuyi, A.T., Geethanath, S., Gulani, V., Nganga, E.C., Adeleke, S., Ntobeuko, N., Minja, F.J., Webb, A.G., Asllani, I., Dako, F., Consortium Adv MRI Educ Res Africa

Publikováno v: NMR in Biomedicine. WILEY
NMR in Biomedicine
the Consortium for Advancement of MRI Education and Research in Africa (CAMERA) 2022, ' A framework for advancing sustainable magnetic resonance imaging access in Africa ', NMR in Biomedicine . https://doi.org/10.1002/nbm.4846
NMR in Biomedicine. John Wiley and Sons Ltd

Magnetic resonance imaging (MRI) technology has profoundly transformed current healthcare systems globally, owing to advances in hardware and software research innovations. Despite these advances, MRI remains largely inaccessible to clinicians, patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d76a47abd993b35757d67fb920c6f343
https://hdl.handle.net/1887/3567639

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

An immunologically relevant rodent model demonstrates safety of therapy using a tumour‐specific IgE

Autor: Josephs, D. H., Nakamura, M., Bax, H. J., Dodev, T. S., Muirhead, G., Saul, L., Karagiannis, P., Ilieva, K. M., Crescioli, S., Gazinska, P., Woodman, N., Lombardelli, C., Kareemaghay, S., Selkirk, C., Lentfer, H., Barton, C., Canevari, S., Figini, M., Downes, N., Dombrowicz, D., Corrigan, C. J., Nestle, F. O., Jones, P. S., Gould, H. J., Blower, P. J., Tsoka, S., Spicer, J. F., Karagiannis, S. N.

Publikováno v: Allergy

Background Designing biologically informative models for assessing the safety of novel agents, especially for cancer immunotherapy, carries substantial challenges. The choice of an in vivo system for studies on IgE antibodies represents a major imped

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9aed7f6b75c297aa078ff14a130f6a98
http://europepmc.org/articles/PMC6492130

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.